Newlink Genetics Cor (NLNK) 11.24 $NLNK The Law Offices

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Newlink Genetics Cor (NLNK) 11.24 $NLNK

The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of NewLink Genetics Corporation Investors and Encourages Investors to Contact the Firm
BusinessWire - Thu Jun 23, 1:21PM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased NewLink Genetics Corporation ("NewLink" or the "Company" (NASDAQ: NLNK) securities between September 17, 2013 and May 9, 2016, inclusive (the "Class Period". NewLink investors have until July 11, 2016 to file a lead plaintiff motion.
NLNK: 11.24 (+0.59)

DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against NewLink Genetics Corporation and Reminds Investors with Losses to Contact the Firm
BusinessWire - Thu Jun 23, 4:30AM CDT
Lundin Law PC announces a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company" (Nasdaq: NLNK) concerning possible violations of federal securities laws between September 17, 2013 and May 9, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 11, 2016 lead plaintiff motion deadline.
NLNK: 11.24 (+0.59)

NEWLINK SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NewLink Genetics Corporation - NLNK
PR Newswire - Fri Jun 10, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 11, 2016 to file lead plaintiff applications in a securities class action lawsuit against NewLink Genetics Corporation (NasdaqGM: NLNK), if they purchased the Company's securities between September 17, 2013 and May 9, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the Southern District of New York.
NLNK: 11.24 (+0.59)

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in NewLink Genetics Corporation of Class Action Lawsuit and Upcoming Deadline - NLNK
ACCESSWIRE - Fri Jun 10, 5:21PM CDT
NEW YORK, NY / ACCESSWIRE / June 10, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed against NewLink Genetics Corporation ("NewLink" or the "Company" (NASDAQ: NLNK) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 16-cv-03545, is on behalf of a class consisting of all persons or entities who purchased NewLink securities between September 17, 2013 and May 9, 2016 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act".
NLNK: 11.24 (+0.59)

INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving NewLink Genetics Corporation and a Lead Plaintiff Deadline of July 11, 2016 - NLNK
GlobeNewswire - Fri Jun 10, 9:51AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased NewLink Genetics Corporation (NASDAQ:NLNK) securities between September 17, 2013 and May 9, 2016.
NLNK: 11.24 (+0.59)

How These Biotech's Stocks are Performing? - Clovis Oncology, Illumina, NewLink Genetics and Zafgen
PR Newswire - Thu Jun 09, 7:00AM CDT
Some of the biggest opportunities in the equities market are found in tumultuous industries such as Biotechnology. The segment continues to present a number of remarkable trades as well as potentially good investment that are waiting to be discovered. This morning ActiveWallSt.com features these four biotech stocks in its technical alerts service: Clovis Oncology Inc. (NASDAQ: CLVS), Illumina Inc. (NASDAQ: ILMN), NewLink Genetics Corp. (NASDAQ: NLNK), and Zafgen Inc. (NASDAQ: ZFGN). Learn more about these stocks and receive your complimentary trade alerts at:
ZFGN: 6.28 (+0.23), CLVS: 13.93 (+0.65), NLNK: 11.24 (+0.59), ILMN: 146.59 (+5.70)

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in NewLink Genetics Corporation to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit - NLNK
GlobeNewswire - Wed Jun 08, 2:22PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of NewLink Genetics Corporation (Nasdaq:NLNK) ("NewLink" or the "Company" securities during the period between September 17, 2013 and May 9, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until July 11, 2016 to seek appointment as lead plaintiff.
NLNK: 11.24 (+0.59)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of NewLink Genetics Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2016 - NLNK
GlobeNewswire - Mon Jun 06, 2:18PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
NLNK: 11.24 (+0.59)

Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal Securities Laws
PR Newswire - Mon Jun 06, 8:11AM CDT
The Law Offices of Marc S. Henzel (www.henzellaw.com), a firm focusing on shareholder litigation, gives notice to shareholders of investigation into the following securities for violations of the Federal Securities Laws:
TNGO: 8.06 (-1.14), ENDP: 15.84 (+0.39), GGB: 1.86 (+0.16), HCP: 34.11 (+0.06), UNIS: 3.20 (unch), NLNK: 11.24 (+0.59), ABIL: 4.35 (-0.05)

NewLink Genetics Presents Clinical Data for IDO Pathway Inhibitor Indoximod Combinations at American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire - Mon Jun 06, 6:00AM CDT
NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology medicines to patients, yesterday presented data from two studies on two posters highlighting the combination therapeutic potential of indoximod, an indoleamine-(2,3)-dioxygenase (IDO) pathway inhibitor, at the 2016 American Society of Clinical Oncology Annual Meeting in Chicago.
NLNK: 11.24 (+0.59)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against NewLink Genetics Corporation (NLNK) and Lead Plaintiff Deadline: July 11, 2016
ACCESSWIRE - Fri Jun 03, 9:51AM CDT
NEW YORK, NY / ACCESSWIRE / June 3, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed on behalf of those who purchased shares of NewLink Genetics Corporation ("NewLink" or the "Company" (NASDAQ: NLNK) between September 17, 2013 and May 9, 2016 inclusive (the "Class Period".
NLNK: 11.24 (+0.59)

NewLink Genetics to Present Data on Indoximod at American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire - Fri Jun 03, 6:00AM CDT
NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it will present two posters highlighting the indoleamine 2,3-dioxygenase pathway (IDO) inhibitor indoximod, at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting on June 5 in Chicago.
NLNK: 11.24 (+0.59)

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Investigation of NewLink Genetics Corporation and Advises Investors With Losses to Contact the Firm
BusinessWire - Thu Jun 02, 2:33PM CDT
Lundin Law PC announces it is investigating claims against NewLink Genetics Corporation ("NewLink" or the "Company" (Nasdaq: NLNK) concerning possible violations of federal securities laws. The investigation is related to allegations that certain statements issued by NewLink were false and misleading and/or failed to disclose material information regarding the Company's financial performance.
NLNK: 11.24 (+0.59)

NewLink Genetics to Participate in Jefferies Healthcare Conference
GlobeNewswire - Thu Jun 02, 6:00AM CDT
NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it will participate in the Jefferies 2016 Healthcare Conference in New York.
NLNK: 11.24 (+0.59)

NewLink Genetics Corporation Top Infectious Disease Scientist to Present at Special Zika Conference Called by American Society for Microbiology
GlobeNewswire - Wed Jun 01, 6:00AM CDT
NewLink Genetics Corporation (NASDAQ:NLNK) today announced that Thomas P. Monath M.D., Chief Science Officer and Chief Operating Officer for the Infectious Disease Division of NewLink Genetics, will present at a scientific conference focused on the Zika virus hosted by the American Society for Microbiology (ASM) in collaboration with the American Society for Virology (ASV).
NLNK: 11.24 (+0.59)

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of NewLink Genetics Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2016 - NLNK
ACCESSWIRE - Tue May 31, 12:42PM CDT
NEW YORK, NY / ACCESSWIRE / May 31, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
NLNK: 11.24 (+0.59)

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in NewLink Genetics Corporation to Contact the Firm Before Lead Plaintiff Deadline
Marketwired - Sat May 28, 10:11AM CDT
NEW YORK, NY--(Marketwired - May 28, 2016) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in NewLink Genetics Corporation ("NewLink" or the "Company" (NASDAQ: NLNK) of the July 11, 2016 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.
NLNK: 11.24 (+0.59)

NEWLINK SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NewLink Genetics Corporation
BusinessWire - Fri May 27, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 11, 2016 to file lead plaintiff applications in a securities class action lawsuit against NewLink Genetics Corporation (NasdaqGM: NLNK), if they purchased the Company's securities between September 17, 2013 and May 9, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the Southern District of New York.
NLNK: 11.24 (+0.59)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Atlas Unveils Luxurious Owner's Suites on New Yacht

Updated Category News Views 4

Set Sail into Opulent Luxury The upcoming debut of the Atlas Adventurer yacht promises to redefine luxury at sea with its exclusive Owner's Suites. Yeah, you heard that right—these aren't your average cabins. Atlas Ocean Voyages is shooting for the stars here, rolling out the yacht's crown jewel of accommodations that's got everyone buzzing. Nestled on Deck 6, above the...

Continue Reading
Mixed Wage Growth: Gains for Some, Challenges Persist

Updated Category News Views 3

A Closer Look at Q3 Earnings I tell you, these numbers from the Ludwig Institute make for a pretty mixed bag. Sure, we got a slight nudge upwards in those median weekly earnings for the third quarter, like from $1,035 to $1,041. It’s a pinch of positive news, but hang on a sec before you start celebrating. The reality ain't shifting for a lot of folks, especially if...

Continue Reading
LFG Charts New Path with Expanded Franchise Lineup

Updated Category News Views 4

A Unique Approach to Franchise Expansion LFG, or Limitless Franchise Growth if you prefer function over flair, is taking its expansion game to a different level. Based out of Scottsdale, these savvy folks have just beefed up their portfolio to nine diverse brand partners. You’d think they’re all about boosting numbers, right? But nah, they're so picky you'd think...

Continue Reading
TransPerfect Launches College Bowl Game in Puerto Rico

Updated Category News Views 3

Puerto Rico Welcomes College Football with Open Arms Imagine kicking towards the goalposts while the ocean breeze kisses your face—yep, that's what's happening in Puerto Rico this December. TransPerfect, a heavyweight in language and tech solutions, is rolling out the red carpet for the inaugural TransPerfect San Juan Bowl, and it’s not just a game. It’s a bold step...

Continue Reading
Low GWP Refrigerants: Potential $13B Market by 2031

Updated Category News Views 4

Refrigerants: They're Hot in More Ways Than One Who would've thought refrigerants could be such a big deal? But here we are. The low global warming potential (GWP) refrigerants market is heating up, projected to jump from $8.17 billion in 2026 to a whopping $13.06 billion by 2031. That's a solid 9.8% CAGR if you're keeping score. The drivers? Well, we’ve got...

Continue Reading
Tucows Preps for Q3 Financial Reveal on November 5th

Updated Category News Views 4

A New Financial Landscape Unfolds Ah, another earnings season looms on the horizon, and Tucows Inc. has flagged November 5, 2026, as the day the curtain rises for its third-quarter financial results. Right after the market closes at exactly 5:05 p.m. ET, Tucows plans to dish out its numbers, giving investors and analysts the meat and potatoes they crave by way of a news...

Continue Reading
Haystack Expands MCP to Boost AI Intranet Workflow

Updated Category News Views 10

Bridging the Intranet and AI: A Game Changer? You ever feel like your company's intranet is a black hole, swallowing all the information you need before spitting it back out in a chaos of outdated pages and broken links? Well, Haystack aims to clear that fog with their Model Context Protocol (MCP) server. And starting October 26, the game takes a leap forward. Now, not...

Continue Reading
D-Wave Investors Face Pressure Ahead of December 15

Updated Category News Views 0

Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...

Continue Reading
Revolutionizing Textiles: Touchscreen Garments Emerge

Updated Category News Views 5

Picture a world where your shirt does more than just cover your back. Bingo, folks—smart textiles have taken center stage with groundbreaking technology that melds touchscreens with fabric, and the brains behind it hail from the National University of Singapore (NUS). It's not just about slapping a few LEDs onto a vest. We're talking about clothing that can display...

Continue Reading
California Waste Solutions: Investing in Vietnam's Future

Updated Category News Views 2

Some folks see trash. David Duong sees hope—and dollar signs. This man ain't just talking trash collection; he's flipping waste into opportunity and, more importantly, into core community building in Vietnam. Over at Vietnam Waste Solutions, a subsidiary of California Waste Solutions, they're blending environmental breakthroughs with good old-fashioned community values....

Continue Reading

Top 5 Most Recently Viewed Articles

GDI Integrated Facility Services Underscores Financial Resilience

Updated Category News Views 201

Financial Performance Overview GDI Integrated Facility Services Inc. recently provided a detailed account of its financial performance for the second quarter of 2025, revealing significant revenue metrics and underlying trends. Quarterly Revenue Analysis During this period, GDI reported a revenue of $610 million, marking a decrease of $29 million or 5% compared to the...

Continue Reading
Marin, Barrett, and Murphy Law Firm Unveils Enhanced Website Experience

Updated Category News Views 47

Marin, Barrett, and Murphy Law Firm Launches New Website The Marin, Barrett, and Murphy Law Firm is thrilled to reveal their newly redesigned website, dedicated to providing clients with premier criminal defense services. This new website reflects the firm’s commitment to offering experienced legal representation and transparent communication, arming clients with the...

Continue Reading
Veradigm Board Transition: Beth Altman's Departure Explained

Updated Category News Views 376

Veradigm Board Transition and Leadership Changes Veradigm® (OTCMKTS: MDRX), a notable leader in healthcare technology solutions, has recently experienced a significant transition in its Board of Directors with the resignation of Beth Altman. This decision was attributed to health reasons and marks a pivotal moment for the company as they continue their commitment to...

Continue Reading
Pfizer's Future: Strategic Initiatives and Market Outlook

Updated Category News Views 1753

Pfizer's Strategic Overview Pfizer Inc. (NYSE: PFE), a well-known global pharmaceutical leader, faces a pivotal moment as it transitions from the pandemic era towards sustainable growth. The company's stock has displayed volatility, thereby necessitating a comprehensive exploration of its strategic maneuvers, product pipelines, and overall market stance. In this analysis,...

Continue Reading
Important Financial Dates to Note for Glunz & Jensen Holding

Updated Category News Views 102

Key Financial Announcements for Glunz & Jensen Holding A/S Glunz & Jensen Holding A/S is dedicated to keeping its shareholders and stakeholders well-informed about their financial activities. By sharing their financial calendar, they ensure that everyone involved can plan accordingly for essential updates and meetings. Upcoming Financial Reporting Schedule Mark your...

Continue Reading